Newsbenzinga
Geron Corporation To Discontinue Phase 3 IMpactMF Clinical Trial Of Imetelstat In Relapsed/Refractory Myelofibrosis
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…